45.69
price up icon0.00%   0.00
after-market After Hours: 45.96 0.27 +0.59%
loading
Doximity Inc stock is traded at $45.69, with a volume of 3.23M. It is up +0.00% in the last 24 hours and down -0.52% over the past month. Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$45.69
Open:
$45.95
24h Volume:
3.23M
Relative Volume:
1.49
Market Cap:
$8.60B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
45.69
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
+2.49%
1M Performance:
-0.52%
6M Performance:
-25.94%
1Y Performance:
-17.78%
1-Day Range:
Value
$44.96
$46.75
1-Week Range:
Value
$43.21
$46.75
52-Week Range:
Value
$43.21
$85.21

Doximity Inc Stock (DOCS) Company Profile

Name
Name
Doximity Inc
Name
Phone
(650) 549-4330
Name
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Name
Employee
830
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
DOCS's Discussions on Twitter

Compare DOCS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
DOCS
Doximity Inc
45.69 8.60B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
VEEV
Veeva Systems Inc
237.87 36.38B 3.08B 860.33M 1.35B 5.1463
Health Information Services icon
TEM
Tempus Ai Inc
69.54 11.51B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
95.45 7.99B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
BTSG
Brightspring Health Services Inc
40.67 7.08B 11.99B 24.18M 234.31M 0.2956

Doximity Inc Stock (DOCS) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-15-25 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-09-25 Initiated Barclays Overweight
Nov-21-25 Upgrade Raymond James Outperform → Strong Buy
Nov-13-25 Initiated BMO Capital Markets Market Perform
Oct-27-25 Upgrade BofA Securities Neutral → Buy
Oct-10-25 Downgrade JP Morgan Neutral → Underweight
Oct-01-25 Downgrade Goldman Neutral → Sell
Jul-09-25 Upgrade Evercore ISI In-line → Outperform
Jun-02-25 Upgrade BTIG Research Neutral → Buy
Feb-07-25 Upgrade Leerink Partners Market Perform → Outperform
Feb-07-25 Upgrade Piper Sandler Neutral → Overweight
Dec-20-24 Initiated Stephens Equal-Weight
Dec-04-24 Initiated Mizuho Neutral
Nov-15-24 Initiated Goldman Neutral
Nov-14-24 Upgrade Morgan Stanley Underweight → Equal-Weight
Nov-13-24 Downgrade Canaccord Genuity Buy → Hold
Nov-08-24 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Nov-08-24 Upgrade Wells Fargo Underweight → Equal Weight
Oct-15-24 Upgrade Barclays Equal Weight → Overweight
Aug-09-24 Upgrade Needham Hold → Buy
Jul-18-24 Downgrade Wells Fargo Equal Weight → Underweight
Apr-25-24 Upgrade JP Morgan Underweight → Neutral
Feb-26-24 Initiated Leerink Partners Market Perform
Jan-03-24 Initiated Barclays Equal Weight
Jan-02-24 Upgrade BofA Securities Underperform → Neutral
Aug-09-23 Downgrade Guggenheim Buy → Neutral
Aug-09-23 Downgrade Needham Buy → Hold
Aug-03-23 Downgrade Piper Sandler Overweight → Neutral
May-01-23 Downgrade Wells Fargo Overweight → Equal Weight
Jan-06-23 Downgrade Morgan Stanley Equal-Weight → Underweight
Oct-31-22 Initiated Wells Fargo Overweight
Oct-24-22 Initiated Evercore ISI In-line
Oct-13-22 Initiated BTIG Research Neutral
Sep-16-22 Initiated KeyBanc Capital Markets Sector Weight
Sep-07-22 Initiated Truist Hold
Aug-05-22 Downgrade BofA Securities Neutral → Underperform
Jul-28-22 Initiated Berenberg Buy
May-18-22 Reiterated BofA Securities Neutral
May-18-22 Reiterated Goldman Buy
May-18-22 Reiterated Guggenheim Buy
May-18-22 Reiterated Jefferies Buy
May-18-22 Reiterated Morgan Stanley Equal-Weight
May-18-22 Reiterated Needham Buy
Apr-07-22 Initiated Guggenheim Buy
Apr-04-22 Initiated BofA Securities Neutral
Feb-11-22 Initiated Goldman Buy
Dec-14-21 Downgrade JP Morgan Neutral → Underweight
Dec-02-21 Initiated Jefferies Buy
Nov-17-21 Initiated Robert W. Baird Outperform
Nov-10-21 Reiterated Canaccord Genuity Buy
Nov-10-21 Reiterated Goldman Neutral
Nov-10-21 Reiterated Morgan Stanley Equal-Weight
Nov-10-21 Reiterated Needham Buy
Nov-10-21 Reiterated Piper Sandler Overweight
Aug-26-21 Downgrade JP Morgan Overweight → Neutral
Jul-19-21 Initiated Canaccord Genuity Buy
Jul-19-21 Initiated Goldman Neutral
Jul-19-21 Initiated JP Morgan Overweight
Jul-19-21 Initiated Morgan Stanley Equal-Weight
Jul-19-21 Initiated Piper Sandler Overweight
Jul-19-21 Initiated Raymond James Outperform
Jul-19-21 Initiated SVB Leerink Outperform
Jul-19-21 Initiated William Blair Outperform
View All

Doximity Inc Stock (DOCS) Latest News

pulisher
01:32 AM

Doximity, Inc. (NASDAQ:DOCS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

01:32 AM
pulisher
Jan 05, 2026

MongoDB, Doximity, DoubleVerify, and 8x8 Shares Skyrocket, What You Need To Know - Finviz

Jan 05, 2026
pulisher
Jan 05, 2026

Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization - TradingView — Track All Markets

Jan 05, 2026
pulisher
Jan 03, 2026

Should You Investigate Doximity, Inc. (NYSE:DOCS) At US$43.29? - Yahoo Finance

Jan 03, 2026
pulisher
Jan 03, 2026

Doximity, Inc. $DOCS Shares Acquired by Synergy Asset Management LLC - MarketBeat

Jan 03, 2026
pulisher
Jan 02, 2026

EPS Watch: Will Doximity Inc stock keep outperforming rivalsPrice Action & Low Risk Growth Stock Ideas - moha.gov.vn

Jan 02, 2026
pulisher
Jan 02, 2026

Doximity (NASDAQ:DOCS) Sets New 12-Month LowTime to Sell? - MarketBeat

Jan 02, 2026
pulisher
Jan 02, 2026

Doximity stock hits 52-week low at 43.22 USD By Investing.com - Investing.com Nigeria

Jan 02, 2026
pulisher
Jan 02, 2026

Doximity stock hits 52-week low at 43.22 USD - Investing.com

Jan 02, 2026
pulisher
Dec 31, 2025

Fort Washington Investment Advisors Inc. OH Has $16.45 Million Position in Doximity, Inc. $DOCS - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Doximity reaches $31M settlement in securities litigation lawsuit - MSN

Dec 31, 2025
pulisher
Dec 30, 2025

Doximity enters into $31 million settlement agreement to resolve securities litigation - marketscreener.com

Dec 30, 2025
pulisher
Dec 30, 2025

DoximityOn December 24, Enters Into $31 Million Settlement Agreement To Resolve Securities Litigation - TradingView — Track All Markets

Dec 30, 2025
pulisher
Dec 30, 2025

Doximity Enters Agreement to Settle Securities Litigation for $31 Million - marketscreener.com

Dec 30, 2025
pulisher
Dec 30, 2025

Doximity to settle securities litigation lawsuit for $31M - TipRanks

Dec 30, 2025
pulisher
Dec 30, 2025

Doximity Reaches Proposed Settlement in Securities Litigation Case - TipRanks

Dec 30, 2025
pulisher
Dec 30, 2025

Doximity reaches $31M settlement in securities litigation lawsuit (DOCS:NYSE) - Seeking Alpha

Dec 30, 2025
pulisher
Dec 30, 2025

Doximity, Inc. Reaches Settlement in Securities Litigation - TradingView — Track All Markets

Dec 30, 2025
pulisher
Dec 30, 2025

Doximity (NYSE: DOCS) agrees to $31M insured settlement in securities case - Stock Titan

Dec 30, 2025
pulisher
Dec 30, 2025

Doximity Agrees to $31 Million Deal to End Investor Class Action - Bloomberg Law News

Dec 30, 2025
pulisher
Dec 30, 2025

Doximity: Strong Growth but What's Next? - AOL.com

Dec 30, 2025
pulisher
Dec 30, 2025

Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More - AOL.com

Dec 30, 2025
pulisher
Dec 29, 2025

Here are Monday’s top Wall Street analyst research calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and more - MSN

Dec 29, 2025
pulisher
Dec 29, 2025

Why Doximity, Inc. (DOCS) Soared Last Week? - MSN

Dec 29, 2025
pulisher
Dec 29, 2025

Raymond James reiterates Strong Buy on Doximity stock, cites physician-first approach By Investing.com - Investing.com Nigeria

Dec 29, 2025
pulisher
Dec 29, 2025

Raymond James reiterates Strong Buy on Doximity stock, cites physician-first approach - Investing.com Nigeria

Dec 29, 2025
pulisher
Dec 28, 2025

Doximity, Inc. $DOCS Shares Sold by Pacer Advisors Inc. - MarketBeat

Dec 28, 2025
pulisher
Dec 28, 2025

Capricorn Fund Managers Ltd Buys New Position in Doximity, Inc. $DOCS - MarketBeat

Dec 28, 2025
pulisher
Dec 27, 2025

How Doximity Inc stock reacts to global recession fears2025 Earnings Surprises & Reliable Intraday Trade Plans - moha.gov.vn

Dec 27, 2025
pulisher
Dec 27, 2025

Rice Hall James & Associates LLC Sells 35,852 Shares of Doximity, Inc. $DOCS - MarketBeat

Dec 27, 2025
pulisher
Dec 25, 2025

What Doximity (DOCS)'s PeerCheck AI Review Launch and Analyst Support Means For Shareholders - Sahm

Dec 25, 2025
pulisher
Dec 24, 2025

HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTAC - GuruFocus

Dec 24, 2025
pulisher
Dec 24, 2025

HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire

Dec 24, 2025
pulisher
Dec 24, 2025

Doximity (NASDAQ:DOCS) Sets New 1-Year LowHere's Why - MarketBeat

Dec 24, 2025
pulisher
Dec 23, 2025

Doximity (DOCS) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com

Dec 23, 2025
pulisher
Dec 23, 2025

Doximity stock hits 52-week low at 43.28 USD By Investing.com - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 23, 2025

Doximity stock hits 52-week low at 43.28 USD - Investing.com

Dec 23, 2025
pulisher
Dec 22, 2025

Doximity (DOCS) Stock Trades Up, Here Is Why - Finviz

Dec 22, 2025
pulisher
Dec 22, 2025

Why Doximity (DOCS) is a Top Growth Stock for the Long-Term - Nasdaq

Dec 22, 2025
pulisher
Dec 22, 2025

Riverbridge Partners LLC Has $40.61 Million Stock Holdings in Doximity, Inc. $DOCS - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

Why BofA Sees Strong Upside for Doximity (DOCS) - Finviz

Dec 22, 2025
pulisher
Dec 21, 2025

BTIG Upgrades Doximity (DOCS) Stock to Buy from Neutral - MSN

Dec 21, 2025
pulisher
Dec 21, 2025

Is Doximity Inc. stock attractive for long term wealth buildingJuly 2025 Reactions & Community Driven Trade Alerts - bolumsonucanavari.com

Dec 21, 2025
pulisher
Dec 20, 2025

Is Doximity Inc. Class stock considered safe havenJuly 2025 Institutional & Target Return Focused Stock Picks - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Doximity, Inc. $DOCS Shares Purchased by Voya Investment Management LLC - MarketBeat

Dec 20, 2025
pulisher
Dec 19, 2025

Clinical decision support's new chessboard - Axios

Dec 19, 2025
pulisher
Dec 19, 2025

Will Doximity Inc. stock outperform tech sector in 2025Forecast Cut & Short-Term High Return Ideas - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How Doximity Inc. stock compares to industry benchmarksWeekly Market Report & Technical Confirmation Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How higher bond yields impact Doximity Inc. Class stockDollar Strength & High Accuracy Trade Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How Doximity Inc. stock reacts to global recession fearsWeekly Profit Analysis & Target Return Focused Picks - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

How rising interest rates impact Doximity Inc. stockBond Market & Weekly Breakout Opportunity Watchlist - Улправда

Dec 18, 2025

Doximity Inc Stock (DOCS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
health_information_services HQY
$95.45
price up icon 2.12%
$40.67
price up icon 3.59%
health_information_services WAY
$32.53
price up icon 2.36%
health_information_services TEM
$69.54
price up icon 7.48%
$48.83
price up icon 4.16%
Cap:     |  Volume (24h):